2015 American Transplant Congress
Desensitization Protocol Including Concomitant Bortezomib and Rituximab Did Not Reduce Calculated PRA Nor Mean MFI Values Among Waitlisted Patients for Deceased Donor Kidney Transplantation
Highly sensitized (HS) patients (pts) seldom have chance to receive deceased donor kidney transplant (DDKT). A desensitization (DES) program including bortezomib was employed to facilitate…2015 American Transplant Congress
National Outcomes of Donation After Cardiac Death (DCD) Liver Transplantation Are Equivalent to Donation After Brain Death (DBD) Liver Transplantation Using Older (DBD) Donor Livers
University of Wisconsin, Madison, WI.
Background: Multiple studies have demonstrated that outcomes of DCD liver transplantation (LTx) are inferior to DBD LTx. Thus DCD liver transplantation represents only 7% of…2015 American Transplant Congress
Comparison of Liver Transplant Outcomes for Recipients With MELD <35 Vs. >35
Div. of Transplantation, Department of Surgery, University of Minnesota, Mpls, MN.
Introduction: Current allocation favors liver recipients with MELD > 35 . We compared liver tx outcomes among two groups based on MELD score at the…2015 American Transplant Congress
Etanercept for Graft Versus Host Disease Following Liver Transplantation
Purpose: Graft versus host disease (GVHD) is a devastating diagnosis and treatment options, such as antithymocyte globulin (ATG), have poor response rates. With a goal…2015 American Transplant Congress
Age, Race and Socioeconomic Factors Have a Strong Influence on Candidates Finding a Living Donor Kidney
Medicine, University of Virginia, Charlottesville, VA.
Living donation is decreasing in the US even as the number of candidates listed for renal transplant continues to rise. We sought to evaluate the…2015 American Transplant Congress
Rituximab With Intravenous Immune Globulin in Sensitized Patients Awaiting Heart Transplant: Does It Work?
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: Highly sensitized heart transplant (HTx) recipients with donor specific antibodies (DSA) are at increased risk of rejection and death. Rituximab with Intravenous Immune Globulin…2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…2015 American Transplant Congress
Simultaneous Cadaveric Pancreas, Living-Donor Kidney Transplantation: Single Center Experience
Surgery and Organ Transplant Center, Asan Medical Center, Seoul, Korea.
BackgroundSimultaneous cadaveric pancreas and living-donor kidney transplantation(SPLK) is an attractive approach for uremic Type I diabetic patients, due to its distinct advantages from living kidney…2015 American Transplant Congress
Assessment of Eating Disorders in Altruistic Organ Donor Candidates: Pitfalls, Red Flags and Practical Suggestions
NewYork-Presbyterian Hospital/Weill Cornell, New York, NY.
The preoperative psychosocial evaluation of potential altruistic organ donors is a means of exploring a patient's motivations for donation as well as identifying any obstacles…2015 American Transplant Congress
CMV-Specific CD154+T-Cells and CMV Disease Status After Liver Or Intestine Transplantation (LTx, ITx)
Background: Preliminary data suggest that measuring host cellular immunity using CMV-specific IFNg+T-cells can potentially enhance decision making about discontinuation of antiviral therapy and secondary prophylaxis…
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 170
- Next Page »